COMP <GO>
PBH vs UNH // GROSS PROFIT MARGIN
Prestige Consumer Healthcare Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: PBH 6
— UNH 7
▲ GROSS PROFIT MARGIN LEADER: UNH
LAST: $48.75 (+2.01%) • MKT CAP: $2.31B
gross-margins
54.70%
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
gross-margins
88.57%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PBH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 54.70% | 88.57% | -33.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 13.80% | 11.47% | +2.33 | PBH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.0x | 16.4x | -9.45 | PBH | /valuation <GO> |
| Free Cash Flow Yield | 10.67% | 6.48% | +4.19 | PBH | /fcf-yield <GO> |
| Operating Margin | 28.40% | 4.82% | +23.58 | PBH | /operating-margins <GO> |
| Net Profit Margin | 17.50% | 3.14% | +14.36 | PBH | /net-margins <GO> |
| Revenue Growth (YoY) | -4.30% | 6.46% | -10.76 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.21 | 3.12 | -0.91 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 59.2 | -6.70 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.3x | 17.7x | -6.44 | PBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.31B | $368.83B | -$366.52B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PBH REV | UNH REV | PBH GROSS % | UNH GROSS % | PBH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.09B | $447.57B | 54.7% | 88.7% | $246.4M | $16.07B |
| FY 2024 | $1.14B | $400.28B | 55.8% | 88.3% | $243.3M | $20.70B |
| FY 2023 | $1.13B | $371.62B | — | 89.6% | $248.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBH // BETA —
UNH // BETA 0.33